Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer

The development of targeted therapies increases treatment options for metastatic castration resistant prostate cancer (mCRPC) patients. There is a need for strong predictive and prognostic signatures to guide physicians in treating mCRPC patients. In this review we unravel the possible actionability...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cells
Main Authors: Devlies, Wout, Eckstein, Markus, Cimadamore, Alessia, Devos, Gaëtan, Moris, Lisa, Van den Broeck, Thomas, Montironi, Rodolfo, Joniau, Steven, Claessens, Frank, Gevaert, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7698403/
https://ncbi.nlm.nih.gov/pubmed/33212909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9112494
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados